|
1
|
Wang J, Yu F, Shang Y, Ping Z and Liu L:
Thyroid cancer: Incidence and mortality trends in China, 2005–2015.
Endocrine. 68:163–173. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
La Vecchia C, Malvezzi M, Bosetti C,
Garavello W, Bertuccio P, Levi F and Negri E: Thyroid cancer
mortality and incidence: A global overview. Int J Cancer.
136:2187–2195. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hughes DT, Haymart MR, Miller BS, Gauger
PG and Doherty GM: The most commonly occurring papillary thyroid
cancer in the United States is now a microcarcinoma in a patient
older than 45 years. Thyroid. 21:231–236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lim H, Devesa SS, Sosa JA, Check D and
Kitahara CM: Trends in thyroid cancer incidence and mortality in
the United States, 1974–2013. JAMA. 317:1338–1348. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ibrahimpasic T, Ghossein R, Shah JP and
Ganly I: Poorly differentiated carcinoma of the thyroid gland:
Current status and future prospects. Thyroid. 29:311–321. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dettmer MS, Schmitt A, Komminoth P and
Perren A: Poorly differentiated thyroid carcinoma: An
underdiagnosed entity. Pathologe. 41 (Suppl 1):S1–S8. 2020.
View Article : Google Scholar
|
|
7
|
González-González L and Alonso J:
Periostin: A matricellular protein with multiple functions in
cancer development and progression. Front Oncol. 8:2252018.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu Y, Huang Z, Cui D and Ouyang G: The
multiaspect functions of periostin in tumor progression. Adv Exp
Med Biol. 1132:125–136. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang M, Gui C, Qiu S, Tang J and Peng Z:
Periostin silencing suppresses the aggressive phenotype of thyroid
carcinoma cells by suppressing the Akt/thyroid stimulating hormone
receptor axis. Cytotechnology. 70:275–284. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Schwartz L, Supuran CT and Alfarouk KO:
The Warburg effect and the hallmarks of cancer. Anticancer Agents
Med Chem. 17:164–170. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang HJ, Hsieh YJ, Cheng WC, Lin CP, Lin
YS, Yang SF, Chen CC, Izumiya Y, Yu JS, Kung HJ, et al: JMJD5
regulates PKM2 nuclear translocation and reprograms HIF-1α-mediated
glucose metabolism. Proc Natl Acad Sci USA. 111:279–284. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Semenza GL: HIF-1 and mechanisms of
hypoxia sensing. Curr Opin Cell Biol. 13:167–171. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Semenza GL: Hypoxia-inducible factor 1
(HIF-1) pathway. Sci STKE. 2007:cm82007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kierans SJ and Taylor CT: Regulation of
glycolysis by the hypoxia-inducible factor (HIF): Implications for
cellular physiology. J Physiol. 599:23–37. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schweppe RE, Klopper JP, Korch C,
Pugazhenthi U, Benezra M, Knauf JA, Fagin JA, Marlow LA, Copland
JA, Smallridge RC and Haugen BR: Deoxyribonucleic acid profiling
analysis of 40 human thyroid cancer cell lines reveals
cross-contamination resulting in cell line redundancy and
misidentification. J Clin Endocrinol Metab. 93:4331–4341. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rueden CT, Schindelin J, Hiner MC, DeZonia
BE, Walter AE, Arena ET and Eliceiri KW: ImageJ2: ImageJ for the
next generation of scientific image data. BMC Bioinformatics.
18:5292017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Vander Heiden MG, Cantley LC and Thompson
CB: Understanding the Warburg effect: The metabolic requirements of
cell proliferation. Science. 324:1029–1033. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sonnenberg-Riethmacher E, Miehe M and
Riethmacher D: Periostin in allergy and inflammation. Front
Immunol. 12:7221702021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ratajczak-Wielgomas K and Dziegiel P: The
role of periostin in neoplastic processes. Folia Histochem
Cytobiol. 53:120–132. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yamaguchi Y: Periostin in skin tissue and
skin-related diseases. Allergol Int. 63:161–170. 2014. View Article : Google Scholar
|
|
22
|
Kudo Y, Iizuka S, Yoshida M, Nguyen PT,
Siriwardena SB, Tsunematsu T, Ohbayashi M, Ando T, Hatakeyama D,
Shibata T, et al: Periostin directly and indirectly promotes tumor
lymphangiogenesis of head and neck cancer. PLoS One. 7:e444882012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang Y, Zhang G, Li J, Tao Q and Tang W:
The expression analysis of periostin in human breast cancer. J Surg
Res. 160:102–106. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Utispan K, Thuwajit P, Abiko Y, Charngkaew
K, Paupairoj A, Chau-in S and Thuwajit C: Gene expression profiling
of cholangiocarcinoma-derived fibroblast reveals alterations
related to tumor progression and indicates periostin as a poor
prognostic marker. Mol Cancer. 9:132010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kikuchi Y, Kunita A, Iwata C, Komura D,
Nishiyama T, Shimazu K, Takeshita K, Shibahara J, Kii I, Morishita
Y, et al: The niche component periostin is produced by
cancer-associated fibroblasts, supporting growth of gastric cancer
through ERK activation. Am J Pathol. 184:859–870. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kusafuka K, Yamashita M, Iwasaki T,
Tsuchiya C, Kubota A, Hirata K, Murakami A, Muramatsu A, Arai K and
Suzuki M: Periostin expression and its supposed roles in benign and
malignant thyroid nodules: An immunohistochemical study of 105
cases. Diagn Pathol. 16:862021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Giusca SE, Amalinei C, Lozneanu L, Ciobanu
Apostol D, Andriescu EC, Scripcariu A, Balan R, Avadanei ER and
Căruntu ID: Heterogeneous periostin expression in different
histological variants of papillary thyroid carcinoma. Biomed Res
Int. 2017:87013862017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bai Y, Kakudo K, Nakamura M, Ozaki T, Li
Y, Liu Z, Mori I, Miyauchi A and Zhou G: Loss of cellular
polarity/cohesiveness in the invasive front of papillary thyroid
carcinoma and periostin expression. Cancer Lett. 281:188–195. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bai Y, Nakamura M, Zhou G, Li Y, Liu Z,
Ozaki T, Mori I and Kakudo K: Novel isoforms of periostin expressed
in the human thyroid. Jpn Clin Med. 1:13–20. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fluge Ø, Bruland O, Akslen LA, Lillehaug
JR and Varhaug JE: Gene expression in poorly differentiated
papillary thyroid carcinomas. Thyroid. 16:161–175. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lee JW, Bae SH, Jeong JW, Kim SH and Kim
KW: Hypoxia-inducible factor (HIF-1)alpha: Its protein stability
and biological functions. Exp Mol Med. 36:1–12. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Maxwell PH, Wiesener MS, Chang GW,
Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER and
Ratcliffe PJ: The tumour suppressor protein VHL targets
hypoxia-inducible factors for oxygen-dependent proteolysis. Nature.
399:271–275. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ivan M, Kondo K, Yang H, Kim W, Valiando
J, Ohh M, Salic A, Asara JM, Lane WS and Kaelin WG Jr: HIFalpha
targeted for VHL-mediated destruction by proline hydroxylation:
Implications for O2 sensing. Science. 292:464–468. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Formenti F, Constantin-Teodosiu D,
Emmanuel Y, Cheeseman J, Dorrington KL, Edwards LM, Humphreys SM,
Lappin TR, McMullin MF, McNamara CJ, et al: Regulation of human
metabolism by hypoxia-inducible factor. Proc Natl Acad Sci USA.
107:12722–12727. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ruas JL, Poellinger L and Pereira T: Role
of CBP in regulating HIF-1-mediated activation of transcription. J
Cell Sci. 118:301–311. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Forsythe JA, Jiang BH, Iyer NV, Agani F,
Leung SW, Koos RD and Semenza GL: Activation of vascular
endothelial growth factor gene transcription by hypoxia-inducible
factor 1. Mol Cell Biol. 16:4604–4613. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kim JW, Tchernyshyov I, Semenza GL and
Dang CV: HIF-1-mediated expression of pyruvate dehydrogenase
kinase: A metabolic switch required for cellular adaptation to
hypoxia. Cell Metab. 3:177–185. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Schmid T, Zhou J and Brüne B: HIF-1 and
p53: Communication of transcription factors under hypoxia. J Cell
Mol Med. 8:423–431. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kudo A: Introductory review:
Periostin-gene and protein structure. Cell Mol Life Sci.
74:4259–4268. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Srinivasan S, Guha M, Dong DW, Whelan KA,
Ruthel G, Uchikado Y, Natsugoe S, Nakagawa H and Avadhani NG:
Disruption of cytochrome c oxidase function induces the Warburg
effect and metabolic reprogramming. Oncogene. 35:1585–1595. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhang Z, Nie F, Kang C, Chen B, Qin Z, Ma
J, Ma Y and Zhao X: Increased periostin expression affects the
proliferation, collagen synthesis, migration and invasion of keloid
fibroblasts under hypoxic conditions. Int J Mol Med. 34:253–261.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Aukkarasongsup P, Haruyama N, Matsumoto T,
Shiga M and Moriyama K: Periostin inhibits hypoxia-induced
apoptosis in human periodontal ligament cells via TGF-β signaling.
Biochem Biophys Res Commun. 441:126–132. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Guo X, Xue H, Shao Q, Wang J, Guo X, Chen
X, Zhang J, Xu S, Li T, Zhang P, et al: Hypoxia promotes
glioma-associated macrophage infiltration via periostin and
subsequent M2 polarization by upregulating TGF-beta and M-CSFR.
Oncotarget. 7:80521–80542. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Liu Y, Gao F and Song W: Periostin
contributes to arsenic trioxide resistance in hepatocellular
carcinoma cells under hypoxia. Biomed Pharmacother. 88:342–348.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Vaupel P and Multhoff G: Revisiting the
Warburg effect: Historical dogma versus current understanding. J
Physiol. 599:1745–1757. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yang Z, Huang R, Wei X, Yu W, Min Z and Ye
M: The SIRT6-autophagy-Warburg effect axis in papillary thyroid
cancer. Front Oncol. 10:12652020. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Semenza GL: Hypoxia-inducible factor 1:
Regulator of mitochondrial metabolism and mediator of ischemic
preconditioning. Biochim Biophys Acta. 1813:1263–1268. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zhang H, Bosch-Marce M, Shimoda LA, Tan
YS, Baek JH, Wesley JB, Gonzalez FJ and Semenza GL: Mitochondrial
autophagy is an HIF-1-dependent adaptive metabolic response to
hypoxia. J Biol Chem. 283:10892–10903. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ordureau A, Münch C and Harper JW:
Quantifying ubiquitin signaling. Mol Cell. 58:660–676. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhang W: The mitophagy receptor FUN14
domain-containing 1 (FUNDC1): A promising biomarker and potential
therapeutic target of human diseases. Genes Dis. 8:640–654. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zhang W, Ren H, Xu C, Zhu C, Wu H, Liu D,
Wang J, Liu L, Li W, Ma Q, et al: Hypoxic mitophagy regulates
mitochondrial quality and platelet activation and determines
severity of I/R heart injury. Elife. 5:e214072016. View Article : Google Scholar : PubMed/NCBI
|
